BSE Live
Oct 13, 16:01Prev. Close
5003.05
Open Price
5000.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 13, 15:58Prev. Close
5007.10
Open Price
5001.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
5005.80 (32)
Balance Sheet of Bayer CropScience (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 44.90 | 44.90 | 44.90 | 44.90 | 44.90 | |
Total Share Capital | 44.90 | 44.90 | 44.90 | 44.90 | 44.90 | |
Reserves and Surplus | 2,805.50 | 2,804.50 | 2,667.20 | 2,479.40 | 2,505.40 | |
Total Reserves and Surplus | 2,805.50 | 2,804.50 | 2,667.20 | 2,479.40 | 2,505.40 | |
Total Shareholders Funds | 2,850.40 | 2,849.40 | 2,712.10 | 2,524.30 | 2,550.30 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Liabilities [Net] | 0.00 | 4.00 | 0.30 | 0.00 | 0.00 | |
Other Long Term Liabilities | 61.60 | 21.00 | 36.40 | 51.80 | 14.10 | |
Long Term Provisions | 110.20 | 125.30 | 152.30 | 117.50 | 104.30 | |
Total Non-Current Liabilities | 171.80 | 150.30 | 189.00 | 169.30 | 118.40 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade Payables | 1,098.40 | 605.10 | 873.20 | 819.80 | 830.30 | |
Other Current Liabilities | 1,038.20 | 940.50 | 791.30 | 729.70 | 676.60 | |
Short Term Provisions | 87.10 | 51.80 | 113.00 | 109.80 | 63.70 | |
Total Current Liabilities | 2,223.70 | 1,597.40 | 1,777.50 | 1,659.30 | 1,570.60 | |
Total Capital And Liabilities | 5,245.90 | 4,597.10 | 4,678.60 | 4,352.90 | 4,239.30 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 426.90 | 376.20 | 428.40 | 437.10 | 393.20 | |
Intangible Assets | 18.20 | 13.20 | 8.40 | 4.30 | 1.50 | |
Capital Work-In-Progress | 0.50 | 6.40 | 2.90 | 13.30 | 7.60 | |
Other Assets | 24.60 | 25.10 | 25.60 | 26.10 | 30.00 | |
Fixed Assets | 588.40 | 533.10 | 571.60 | 565.80 | 501.00 | |
Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax Assets [Net] | 9.70 | 0.00 | 0.00 | 7.30 | 17.90 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Non-Current Assets | 176.20 | 158.50 | 210.60 | 204.30 | 176.50 | |
Total Non-Current Assets | 774.30 | 691.60 | 782.20 | 777.40 | 695.40 | |
CURRENT ASSETS | ||||||
Current Investments | 35.40 | 53.90 | 41.10 | 38.50 | 52.20 | |
Inventories | 2,361.80 | 1,545.20 | 1,807.20 | 1,512.00 | 1,325.10 | |
Trade Receivables | 952.10 | 960.10 | 975.60 | 1,004.70 | 754.90 | |
Cash And Cash Equivalents | 893.70 | 1,164.00 | 868.00 | 787.40 | 1,209.50 | |
Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
OtherCurrentAssets | 228.60 | 182.30 | 204.50 | 232.90 | 202.20 | |
Total Current Assets | 4,471.60 | 3,905.50 | 3,896.40 | 3,575.50 | 3,543.90 | |
Total Assets | 5,245.90 | 4,597.10 | 4,678.60 | 4,352.90 | 4,239.30 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 695.80 | 562.90 | 372.70 | 366.60 | 292.30 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 46.30 | 55.30 | 77.70 | 60.90 | 130.50 | |
Trade/Other Goods | 46.30 | 55.30 | 77.70 | 60.90 | 130.50 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 8.50 | 13.00 | 63.80 | 64.50 | 62.10 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | 107.60 | 56.20 | 91.30 | 93.40 | 172.30 | |
Other Earnings | 44.80 | 29.10 | 63.80 | 53.10 | 35.10 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 10.97 | 10.97 | 10.97 | 10.97 | 10.97 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | 35.40 | 53.90 | 41.10 | 38.50 | 52.20 |
07.08.2025
Bayer CropScien Standalone June 2025 Net Sales at Rs 1,914.60 crore, up 17.37% Y-o-Y
01.08.2025
27.05.2025
17.02.2025
Bayer CropScien Standalone December 2024 Net Sales at Rs 1,056.90 crore, up 10.68% Y-o-Y
07.08.2025
Bayer CropScien Standalone June 2025 Net Sales at Rs 1,914.60 crore, up 17.37% Y-o-Y
27.05.2025
17.02.2025
Bayer CropScien Standalone December 2024 Net Sales at Rs 1,056.90 crore, up 10.68% Y-o-Y
25.11.2024
Bayer CropScien Standalone September 2024 Net Sales at Rs 1,737.60 crore, up 7.44% Y-o-Y